Eledon Pharmaceuticals, Inc. (ELDN) stock
ELDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.98+0.01 (+0.51%)
Close on Nov 17, 2026Market cap $160.90MP/E –Yield –
Eledon Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Eledon Pharmaceuticals's price to book ratio was 6.5× on Nov 11, 2026, against 2.8× a year earlier. Over the last 5 years it ranged from 0.2× to 9.4×, with a median of 1.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 6.5× | +4.0 |
| 2025 | Dec 31, 2025 | 2.6× | −5.8 |
| 2024 | Dec 31, 2024 | 8.3× | +7.1 |
| 2023 | Dec 29, 2023 | 1.2× | +1.0 |
| 2022 | Dec 30, 2022 | 0.2× | −0.1 |
| 2021 | Dec 31, 2021 | 0.4× | −0.5 |
| 2020 | Dec 31, 2020 | 0.9× | +0.3 |
| 2019 | Dec 31, 2019 | 0.6× | −0.3 |
| 2018 | Dec 31, 2018 | 0.8× | −0.5 |
| 2017 | Dec 29, 2017 | 1.4× | +1.3 |
| 2016 | Dec 30, 2016 | 0.0× | −0.1 |
| 2015 | Dec 31, 2015 | 0.1× | −0.0 |
| 2014 | Dec 31, 2014 | 0.1× | – |
See a number that looks wrong?